Continuing with our efforts to bring the results generated in the lab to our patients, and in line with our previous achievement granted by ASEICA-La Caixa, we have been selected by Fundación Parque Científico de Madrid as part of the program APTEnisa Start 2024. We continue pushing our project focused on a blood-based liquid biopsy to identify patients suffering from colon polyps or tumors.
